SKYE · Skye Bioscience, Inc.
$0.42
-0.08 (-16.03%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If adequate funds are not available to the Company when needed it will be required to curtail or perhaps cease operations which would, in turn, further raise substantial doubt about its ability to continue as a going concern. These conditions give rise to substantial doubt as to the Company's ability to continue as a going concern within one year after the date that these financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$17.76M
Shares
35.42M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding SKYE
11 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 561,832 | $345,302 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 184,978 | $113,687 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 132,808 | $102,979 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | — | 50,202 | $30,854 | 0.00% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 30,637 | $23,756 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 24,379 | $18,903 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 18,888 | $14,646 | 0.00% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 17,647 | $10,846 | 0.00% | Long | 2026-03-31 | |
| Small-Mid Cap Equity Fund | MSLC | 820 | $3,682 | 0.00% | Long | 2024-11-30 | |
| 1290 VT Micro Cap Portfolio | — | 3,385 | $2,080 | 0.00% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 300 | $184 | 0.00% | Long | 2026-03-31 |
Showing 1–11 of 11 positions
Key facts
CIK
1516551
CUSIP
83086J200
13F (30d)
43 filings
43 filers
Visit website
Investor relations